Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001686 · ClinicalTrials.gov registry record
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 482
- Enrollment target
NCT00001686: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001686 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 482 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001686 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 482 participants
- Enrollment target
Study Summary
This protocol is designed to evaluate children with cancer who appear to be probable candidates for future protocol entry or have disease manifestations that are of unique scientific importance or educational value.
Primary Outcome
evaluate longitudinally children and adults with cancer, pre-canceroussyndromes or rare diseases referred to the Pediatric Oncology Branch (POB) who present with disease manifestations that lend themselves to clinical evaluation and are of unique scientific importance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 482 participants |
| Start Date | 1998-03-19 |
| Est. Completion | 2020-09-02 |
What the finished NCT00001686 record still lists
NCT00001686 is an observational study that tracks outcomes without assigning an intervention. The registered 482 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00001686 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001686 about?
NCT00001686 is a clinical study titled "Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases". This protocol is designed to evaluate children with cancer who appear to be probable candidates for future protocol entry or have disease manifestations that are of unique scientific importance or educational value.
What is the current status of trial NCT00001686?
This trial is currently completed. The enrollment target is 482 participants. The study started on 1998-03-19. Estimated completion is 2020-09-02.
Who is sponsoring clinical trial NCT00001686?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI